Back

Reversed U-curve technique enhances mapping and ablation efficiency in the treatment of pulmonary sinus cusp-derived ventricular arrhythmia

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Catheter ablation for ventricular arrhythmias Ablation of Ventricular Arrhythmias ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Xiaonan Dong

Fuwai Hospital, CAMS and PUMC, Beijing (China)

7 More presentations in this session

Presentation thumbnail
Impact of contact force sensing technology on catheter ablation success of idiopathic premature ventricular contractions originating from the outflow tracts
Professor P. Ammann (St Gallen, CH)
Abstract Slides Video
Presentation thumbnail
Reversal of left ventricular dysfunction following catheter ablation in AF patients with LVEF less than 40%
Doctor S. Mohanty (Austin, US)
Abstract Slides Video
Presentation thumbnail
Outcomes after catheter ablation for treatment of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia
Doctor M. Laredo (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Cerebral protection during catheter ablation of ventricular tachycardia in patients with ischemic heart disease
Doctor C. Heeger (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Optimal left ventricular access route for scar-related VT ablation in patients with ischemic cardiomyopathy: Insights from contact force sensing
Assistant Professor A. AbdelWahab (Halifax, CA)
Abstract

Access the full session

Session thumbnail
Catheter ablation for ventricular arrhythmias

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources